Literature DB >> 10452640

Clinical case definitions for Argentine hemorrhagic fever.

L H Harrison1, N A Halsey, K T McKee, C J Peters, J G Barrera Oro, A M Briggiler, M R Feuillade, J I Maiztegui.   

Abstract

Argentine hemorrhagic fever (AHF) is a potentially lethal infection in Argentina. The case-fatality ratio is >15%, but treatment reduces the mortality rate to <1%. Diagnosis is based on clinical and laboratory criteria, but no case definition has been validated. A chart review was conducted for patients hospitalized with suspected AHF. Individuals with a fourfold rise in antibody titer were classified as cases. The combination of a platelet count of <100,000/mm3 and a white blood cell (WBC) count of <2,500/mm3 had a sensitivity and specificity of 87% and 88%, respectively, thus suggesting that the use of these criteria in a case definition would be helpful for epidemiological studies of AHF. The combination of a platelet count of <100,000/mm3 and a WBC count of <4,000/mm3 had a sensitivity of 100% and a specificity of 71%; the use of these criteria in a case definition should be helpful for screening patients for therapy with immune plasma in the region where AHF is endemic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452640     DOI: 10.1086/514749

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

Review 1.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells.

Authors:  Benson Y H Cheng; Emilio Ortiz-Riaño; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Vis Exp       Date:  2013-08-01       Impact factor: 1.355

3.  Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease.

Authors:  Sebastien F Emonet; Alexey V Seregin; Nadezhda E Yun; Allison L Poussard; Aida G Walker; Juan C de la Torre; Slobodan Paessler
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

4.  The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response.

Authors:  Emilio Ortiz-Riaño; Benson Yee Hin Cheng; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice.

Authors:  Michael Patterson; Alexey Seregin; Cheng Huang; Olga Kolokoltsova; Jennifer Smith; Milagros Miller; Jeanon Smith; Nadezhda Yun; Allison Poussard; Ashley Grant; Bersabeh Tigabu; Aida Walker; Slobodan Paessler
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

6.  Identification of critical amino acids within the nucleoprotein of Tacaribe virus important for anti-interferon activity.

Authors:  Brooke Harmon; Carol Kozina; Dianna Maar; Timothy S Carpenter; Catherine S Branda; Oscar A Negrete; Bryan D Carson
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

7.  Junín virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling.

Authors:  Roberto G Pozner; Agustín E Ure; Carolina Jaquenod de Giusti; Lina P D'Atri; Joseph E Italiano; Oscar Torres; Victor Romanowski; Mirta Schattner; Ricardo M Gómez
Journal:  PLoS Pathog       Date:  2010-04-15       Impact factor: 6.823

8.  Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs.

Authors:  Nadezhda E Yun; Nathaniel S Linde; Natallia Dziuba; Michele A Zacks; Jeanon N Smith; Jennifer K Smith; Judy F Aronson; Olga V Chumakova; Heather M Lander; Clarence J Peters; Slobodan Paessler
Journal:  Am J Trop Med Hyg       Date:  2008-08       Impact factor: 2.345

9.  The z protein of the new world arenavirus tacaribe virus has bona fide budding activity that does not depend on known late domain motifs.

Authors:  Shuzo Urata; Jiro Yasuda; Juan Carlos de la Torre
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

Review 10.  Wanted, dead or alive: new viral vaccines.

Authors:  Ian J Amanna; Mark K Slifka
Journal:  Antiviral Res       Date:  2009-09-04       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.